<b>Gapping up <br/>In reaction to strong earnings/guidance:</b><br/>SKYS +65.8%, (thinly traded), OSUR +23.4%, AVNW +15.9%, (thinly traded), TZOO +11.6%, PAYC +11%, ZEN +10.1%, MPAA +9.8%, CLF +9.8%, PCMI +9.5%<br/>IMPV +9.3%, (also agrees to sell its Skyfence technology and service to Forcepoint, financial details not disclosed; acquires the assets of Camouflage Software)<br/>WSTL +8.4%, FLT +7.8%, PRLB +6.5%, SCSS +6.2%, MDSO +6.1%, LLNW +5.4%, CXW +5.2%, LIVE +4.4%, ARRY +3.5%, ALNY +3.4%, RLGT +3.4%<br/>VIA +3%, CMP +2.9%, FONR +2.7%, AOSL +2.5%, GPRE +2.2%, CVS +2.2%, MFC +2%, EFX +1.9%, TU +1.9%, CETX +1.9%, FORM +1.6%, CMI +1.6%<br/>PTN +1.4%, WWE +1.4%, BGCP +1.3%, ROP +1.2%, RAI +1.1%, PSEC +1%, TOT +1%, RMR +0.9%, OHI +0.8%, CRAY +0.8%, AFG +0.7%, YUM +0.6%, PRU +0.5%<br/><b>M&A news:</b><br/>JAGX +69% (Jaguar Animal Health to merge with Napo Pharmaceuticals)<br/>NOK +1.4% (to acquire Comptel for EUR 347 mln)<br/><b>Other news:</b><br/>ETRM +17.8% (publication of three-year data from the Company's VBLOC DM2 Study of vBloc Neurometabolic Therapy)<br/>AQMS +16.1% (announces that Johnson Controls (JCI) finalized an agreement covering North America, China and Europe for its technology)<br/>RELV +14.7% (thinly traded; announced that CardioSentials heart health supplement has earned a U.S. patent)<br/>ACOR +12.3% (announces 'positive' Phase 3 data of CVT-301 'showing a statistically significant improvement in motor function in people with Parkinson's disease experiencing OFF periods)<br/>VKTX +11.7% (announces 'positive' initial results from a proof-of-concept study of VK2809)<br/>PPHM +9.9% (announces the publication of positive proof-of-concept data for a novel exosome-based cancer detection platform)<br/>BANC +5.6% (Banc of California appoints Richard Lashley, co-founder of 6.9% holder PL Capital Advisors, to the Board and approves certain enhancements to corporate governance policies)<br/>URRE +3.8% (announces its Special meeting not convened, nor adjourned to later date; RCF debt to be repaid from treasury)<br/>STB +3.2% ( awarded new record $187 million contract )<br/>SNY +2.3% (Regeneron Pharma confirms appeals court grants stay of permanent injunction for Praluent (alirocumab) during appeals process)<br/>TSLA +2.1% (Reuters details that Tesla (TSLA) plans to pause factory production in California to prepare for Model 3)<br/>XGTI +2.1% (prices offering of 1.75 mln shares of common stocks and warrants of up to 1.3 mln shares at $2.00 per share)<br/>ETP +1.7% (received US Army Corps of Engineers easement to construct N Dakota pipeline (as expected - see Feb 7 comments); Dakota Access has now received all federal authorizations necessary to proceed)<br/>BP +1.1% (in sympathy with TOT earnings)<br/>RDS.A +1.1% (in sympathy with TOT earnings)<br/>DECK +0.9% (following late move higher on Marcato active stake disclosure)<br/>BA +0.8% (confirms that Singapore Airlines has commited to purchase 20 777-9s and 19 787-10 Dreamliners)<br/><b>Analyst comments:</b><br/>RMBS +2.8% (upgraded to Overweight from Neutral at JP Morgan)<br/>FNV +0.7% (upgraded to Neutral from Sell at Goldman)<br/>ALV +0.6% (upgraded to Overweight from Sector Weight at KeyBanc Capital Mkts)<br/><br/><b>Gapping down<br/>In reaction to disappointing earnings/guidance:</b><br/>SNCR -15.9%, LPSN -15.2%, FSC -13.4%, MTRX -10.6%, MB -10.5%, QLYS -9.1%, TWTR -8.9%, IRBT -8.8%, BGC -8%, VSTO -7.6%, SON -7.5%, OII -7%<br/>MXL -6.9%, LQDT -6.8%, GLUU -6%, STRL -5.8%, (sees Q4 net loss of $5.5-6.5 mln and revs of $165-170 mln vs. $157.25 mln two analyst estimate; says results are 'very disappointing')<br/>ECHO -5.3%, COTY -5.2%, ENSG -5%, TYL -4.8%, CDE -4.2%, TBI -3.6%, KS -3.4%, ENTA -3.3%, UHAL -3%, MC -3%, SNN -2.9%, FSFR -2.8%, FISV -2.6%<br/>PPC -2.1%, KO -2.1%, GLAD -1.7%, AGTC -1.5%, MAS -1.5%, CTL -1.4%, PDS -1.3%, DTE -1.2%, REGN -1.2%, JE -1%, CX -0.6%, SEE -0.5%<br/><b>Other news:</b><br/>SRRA -9.1% (to offer shares of its common stock in an underwritten public offering; size not disclosed)<br/>CREE -5.5% (CFIUS informed Infineon and Cree that the Wolfspeed transaction poses a risk to the national security of the United States)<br/>AMGN -1.4%/ REGN -1.2% (Regeneron Pharma confirms appeals court grants stay of permanent injunction for Praluent (alirocumab) during appeals process)<br/>TM -1.2% (traded ~2% lower in Japan overnight)<br/>HLI -1.1% (prices offering of 8 mln shares of common stock by co and selling shareholders at $29.25 per share)<br/>FSLR -1% (awarded module supply contract for the 140 megawatt DC Sun Metals Solar Farm in North Queensland)<br/>PYPL -0.9% (discloses that it has received subpoenas from the DOJ seeking the production of certain information related to the company's historical anti-money laundering program)<br/>KR -0.9% (WFM sympathy)<br/><b>Analyst comments:</b><br/>SLW -1% (downgraded to Neutral from Buy at Goldman)<br/>FCX -1% (resumed with a Neutral at JP Morgan)<br/><br/>Briefing.com